ArticleClinical pharmacology : advances and applications2023

A Phase 1, Multicenter, Open-Label Study to Evaluate the Pharmacokinetics of Iberdomide in Subjects with Mild, Moderate, or Severe Hepatic Impairment Compared with Healthy Subjects.

Yiming Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.